12:00 AM
Sep 27, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

GL701 prasterone: Phase III

GNLB said that preliminary data from its 381-patient Phase III study were positive. The primary end point of the study was...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >